Regulatory Updates
🇺🇸 FDA Page 7FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 73–84 of 382 articles
Top 10 Pharmaceutical Stocks to Buy for June 2026: A B2B Analysis
FDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies
STAT Supreme Court backs generic drugmaker in 'skinny labeling' case: Implications for pharma BD and investors
FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals
Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
Abivax Ulcerative Colitis Drug Shows Strong Efficacy, But Cases of Cancer Raise Concerns
FDA's Future: Insights from Former Commissioner David Kessler
Kailera's Triple-G Drug: A Potential Game-Changer in Pharma
Drug Discovery USA 2026: What to Expect
FDA Flashback: Key Breast Cancer Decisions from April 2026